PER 3.70% 8.4¢ percheron therapeutics limited

atl1103 anti cancer medications

  1. 2,843 Posts.
    Thought i would change the thread to more reflect on the Antisense business model ATL1103 for cancer diabetes and acromegaly.(all in huge demand gobally).

    http://somavert.com/

    Pfizer own this drug and you can research for yourselves the enormity of Somavert.

    If ATL1103 can deliver the clinical success as shown in Primates and after lots of research i believe we do have a 95% success rate in my viw, imagine the huge market demand for Antisense ATL1103.
    Globally it will be huge and ATL1103 should have a very good toxiclogy.
    In my view we are about to hit the big time.ISIS firmly on boardas a partner.Awaiting Clinical trial results eagerly.
    Robbbbsssttarrrrr

    http://imagesignal.comsec.com.au/asxdata/20110816/pdf/01207431.pdf
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.003(3.70%)
Mkt cap ! $75.73M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $79.19K 960.1K

Buyers (Bids)

No. Vol. Price($)
1 100200 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 114242 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.